Elizabeth C Fontao Calana, PA

Dr Lekakis is a Professor of Medicine who joined the University of Miami in 2010 and became an attending physician for Hemotology/Oncology and Blood and Marrow Transplantation in 2012. He has since started the CAR-T trials, performed the first CAR-T for solid tumors, and transplanted adult sickle cell disease patients. Dr Lekakis is a member of the USA CAR-T Consortium and several CIBMTR committees including CAR-T, Lymphoma, Leukemia, and GVHD. His main interests are CAR-T and GVHD.

Dr Jimenez Jimenez, who joined the Division of Transplantation and Cell Therapy in 2016, leads Sylvester's Mismatched Allogeneic Transplant Program. His clinical and research work is dedicated to improving access to Hematopoietic Cell Transplantation (HCT) for ethnically diverse patients who lack suitable donors. A national leader in mismatched HCT, Dr Jimenez chairs multiple trials and played a key role in establishing Sylvester's program. He also focuses on strategies to reduce relapse risk in patients with acute leukemias and myeloid neoplasms post-transplant.